Biotech, Pharmaceutical and Clinical Research Jobs | BioSpace

A woman with her head in her hands/Courtesy of Shu

Latest Data for Karuna’s Schizophrenia Drug Spark Investor Concern

Analysts point to a missed secondary endpoint and cardiovascular risks that may delay FDA approval as possible reasons for the unexpected drop in Karuna's stock following the data reveal.

AbbVie building in the twilight_AbbVie_© AbbVie In

AbbVie Clinches Back-to-Back Clinical Wins in Ulcerative Colitis, Lupus

In a double data drop Thursday, AbbVie touted two clinical trial wins, for Skyrizi in ulcerative colitis and Rinvoq in systemic lupus erythematosus.

NICE Backs PTC’s Gene Therapy for Ultra-Rare Pediatric Disease

An exterior rendering of Lincoln Yards, courtesy o

Sponsored: Inspirational Space Sparks Scientific Innovation at the First Life Sciences Building in Chicago’s Lincoln Yards

Biogen sign in front of office building/courtesy o

FDA Adcomm Backs Accelerated Approval of Biogen’s Tofersen in SOD1-ALS

More Top Stories

View all Featured Employers

Photo shows employees looking at a computer/Getty

When Experience Becomes a Barrier: Ageism at Work

Pictured: Person checking stocks on phone and comp

How to Hold onto Stocks and Equity After a Layoff

Show Me the Money: US Life Sciences Salaries, By Region

A woman with her head in her hands/Courtesy of Shu

3/24/2023

Latest Data for Karuna’s Schizophrenia Drug Spark Investor Concern

AbbVie building in the twilight_AbbVie_© AbbVie In

3/24/2023

AbbVie Clinches Back-to-Back Clinical Wins in Ulcerative Colitis, Lupus

3/24/2023

NICE Backs PTC’s Gene Therapy for Ultra-Rare Pediatric Disease

An exterior rendering of Lincoln Yards, courtesy o

3/24/2023

Sponsored: Inspirational Space Sparks Scientific Innovation at the First Life Sciences Building in Chicago’s Lincoln Yards

Biogen sign in front of office building/courtesy o

3/23/2023

FDA Adcomm Backs Accelerated Approval of Biogen’s Tofersen in SOD1-ALS

View all Hotbeds

A woman with her head in her hands/Courtesy of Shu

3/24/2023

Latest Data for Karuna’s Schizophrenia Drug Spark Investor Concern

AbbVie building in the twilight_AbbVie_© AbbVie In

3/24/2023

AbbVie Clinches Back-to-Back Clinical Wins in Ulcerative Colitis, Lupus

Biogen sign in front of office building/courtesy o

3/23/2023

FDA Adcomm Backs Accelerated Approval of Biogen’s Tofersen in SOD1-ALS

A technician holds up an X-ray of lungs/Courtesy o

3/23/2023

Dupixent Clears Phase III in Bid to Become First Biologic for COPD

A woman with her head in her hands/Courtesy of Shu

Latest Data for Karuna’s Schizophrenia Drug Spark Investor Concern

An exterior rendering of Lincoln Yards, courtesy o

Sponsored: Inspirational Space Sparks Scientific Innovation at the First Life Sciences Building in Chicago’s Lincoln Yards

Silvia Taylor, EVP, chief corporate affairs and ad

The Rise, Fall and Future of Novavax

Don Murray/Getty Images

GSK Abandons COVID-19 Collaboration with Vir

Women in Life Sciences

2023 State of the Recruitment Market

2023 State of the Recruitment Market

U.S. Life Sciences Salary Report

Best Places to Work in Biopharma